Zbigniew Celewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zbigniew Celewicz has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Krzysztof Safranow
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-204 Szczecin, Poland
6 shared publications - Bogusław Machaliński
Department of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland
5 shared publications - Tomasz Miazgowski
Department of Hypertension and Internal Diseases, Pomeranian Medical University, Szczecin, Poland
5 shared publications - Edyta Paczkowska
Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland
4 shared publications Jarosław Ogonowski
Outpatient Clinic for Diabetic Pregnant Women, Provincial Hospital, Szczecin, Poland
4 shared publications- Violetta Dziedziejko
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-111 Szczecin, Poland
4 shared publications
Latest Publications
- 1 January 2025
- Published by Pomorski Uniwersytet Medyczny w Szczecinie in Pomeranian Journal of Life Sciences
- Vol. 71 (4) , 13-16
The usefulness of spatial assessment of proximal femoral morphology in preoperative planning of cementless hip arthroplasty
- 1 January 2025
- Published by Pomorski Uniwersytet Medyczny w Szczecinie in Pomeranian Journal of Life Sciences
- Vol. 71 (4) , 13-16
The usefulness of spatial assessment of proximal femoral morphology in preoperative planning of cementless hip arthroplasty
- Open Access
- 30 November 2021
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 92 (11) , 812-817
The possible role of corticosterone in regulating sodium and potassium concentrations in human milk
Objectives: The aim of the study was to find the presence of corticosterone as a regular human milk constituent. We have evaluated the correlation of concentrations between the analyzed hormone and sodium and potassium in breast milk and serum. Material and methods: Hand expressing breast milk samples and median cubital vein blood samples had been taken from 69 healthy, lactating women in early puerperium period (between the 3rd and 10th day) twice, before and after breastfeeding. Corticosterone concentrations in human plasma and breast milk were determined by radioimmunoassayed method. Direct assays were performed before and after breastfeeding, twice. The serum and milk sodium and potassium concentrations were estimated by Flame Emission analyzer CIBA-Corning 480, equipped with an automatic diluter. Results: Corticosterone was found in all milk samples, which is an original observation, and its concentration in milk was a few times lower than in serum. Its concentration values in human serum when were not higher than 3 nmol/L (n = 108) positively correlated with its concentrations in milk, and those exceeding 3 nmol/L (n = 30) have demonstrated a negative correlation. An original finding has shown a positive correlation between concentrations of corticosterone in human serum and of potassium in human milk (r = 0.018, p < 0.03). An attempt was also made to determine the presence of aldosterone in breast milk, but the radioimmunoassay did not reveal its presence. Conclusions: The results confirm a relation between potassium concentration in milk and serum corticosterone concentration delivered to mammal gland with blood. Objectives: The aim of the study was to find the presence of corticosterone as a regular human milk constituent. We have evaluated the correlation of concentrations between the analyzed hormone and sodium and potassium in breast milk and serum. Material and methods: Hand expressing breast milk samples and median cubital vein blood samples had been taken from 69 healthy, lactating women in early puerperium period (between the 3rd and 10th day) twice, before and after breastfeeding. Corticosterone concentrations in human plasma and breast milk were determined by radioimmunoassayed method. Direct assays were performed before and after breastfeeding, twice. The serum and milk sodium and potassium concentrations were estimated by Flame Emission analyzer CIBA-Corning 480, equipped with an automatic diluter. Results: Corticosterone was found in all milk samples, which is an original observation, and its concentration in milk was a few times lower than in serum. Its concentration values in human serum when were not higher than 3 nmol/L (n = 108) positively correlated with its concentrations in milk, and those exceeding 3 nmol/L (n = 30) have demonstrated a negative correlation. An original finding has shown a positive correlation between concentrations of corticosterone in human serum and of potassium in human milk (r = 0.018, p < 0.03). An attempt was also made to determine the presence of aldosterone in breast milk, but the radioimmunoassay did not reveal its presence. Conclusions: The results confirm a relation between potassium concentration in milk and serum corticosterone concentration delivered to mammal gland with blood.
- 30 November 2021
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 92 (11) , 812-817
Open AccessThe possible role of corticosterone in regulating sodium and potassium concentrations in human milk
Objectives: The aim of the study was to find the presence of corticosterone as a regular human milk constituent. We have evaluated the correlation of concentrations between the analyzed hormone and sodium and potassium in breast milk and serum. Material and methods: Hand expressing breast milk samples and median cubital vein blood samples had been taken from 69 healthy, lactating women in early puerperium period (between the 3rd and 10th day) twice, before and after breastfeeding. Corticosterone concentrations in human plasma and breast milk were determined by radioimmunoassayed method. Direct assays were performed before and after breastfeeding, twice. The serum and milk sodium and potassium concentrations were estimated by Flame Emission analyzer CIBA-Corning 480, equipped with an automatic diluter. Results: Corticosterone was found in all milk samples, which is an original observation, and its concentration in milk was a few times lower than in serum. Its concentration values in human serum when were not higher than 3 nmol/L (n = 108) positively correlated with its concentrations in milk, and those exceeding 3 nmol/L (n = 30) have demonstrated a negative correlation. An original finding has shown a positive correlation between concentrations of corticosterone in human serum and of potassium in human milk (r = 0.018, p < 0.03). An attempt was also made to determine the presence of aldosterone in breast milk, but the radioimmunoassay did not reveal its presence. Conclusions: The results confirm a relation between potassium concentration in milk and serum corticosterone concentration delivered to mammal gland with blood. Objectives: The aim of the study was to find the presence of corticosterone as a regular human milk constituent. We have evaluated the correlation of concentrations between the analyzed hormone and sodium and potassium in breast milk and serum. Material and methods: Hand expressing breast milk samples and median cubital vein blood samples had been taken from 69 healthy, lactating women in early puerperium period (between the 3rd and 10th day) twice, before and after breastfeeding. Corticosterone concentrations in human plasma and breast milk were determined by radioimmunoassayed method. Direct assays were performed before and after breastfeeding, twice. The serum and milk sodium and potassium concentrations were estimated by Flame Emission analyzer CIBA-Corning 480, equipped with an automatic diluter. Results: Corticosterone was found in all milk samples, which is an original observation, and its concentration in milk was a few times lower than in serum. Its concentration values in human serum when were not higher than 3 nmol/L (n = 108) positively correlated with its concentrations in milk, and those exceeding 3 nmol/L (n = 30) have demonstrated a negative correlation. An original finding has shown a positive correlation between concentrations of corticosterone in human serum and of potassium in human milk (r = 0.018, p < 0.03). An attempt was also made to determine the presence of aldosterone in breast milk, but the radioimmunoassay did not reveal its presence. Conclusions: The results confirm a relation between potassium concentration in milk and serum corticosterone concentration delivered to mammal gland with blood.
- Open Access
- 30 November 2020
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 91 (11) , 709-713
Perinatal factors affecting the gut microbiota — are they preventable?
Intestinal microbiota affects many aspects of physiological processes. The type of microbiota in the early stages of life is a critical element conditioning the development of the immune response and food tolerance. Disturbed colonization of the digestive tract resulting from the amount or diversity of bacteria colonies stimulates an inflammatory response that is associated in later life with inflammatory and autoimmune diseases. One of the elements disturbing normal colonization in the perinatal period is the operative way of delivery by caesarean section and the administration of antibiotics, used as a prophylactic measure as well as for therapeutic reasons. Based on the current state of knowledge, there is a lot of evidence demonstrating the long-term adverse effects of these modifying agents for gut microbiota, which should be kept to a minimum as far as possible. Intestinal microbiota affects many aspects of physiological processes. The type of microbiota in the early stages of life is a critical element conditioning the development of the immune response and food tolerance. Disturbed colonization of the digestive tract resulting from the amount or diversity of bacteria colonies stimulates an inflammatory response that is associated in later life with inflammatory and autoimmune diseases. One of the elements disturbing normal colonization in the perinatal period is the operative way of delivery by caesarean section and the administration of antibiotics, used as a prophylactic measure as well as for therapeutic reasons. Based on the current state of knowledge, there is a lot of evidence demonstrating the long-term adverse effects of these modifying agents for gut microbiota, which should be kept to a minimum as far as possible.
- 30 November 2020
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 91 (11) , 709-713
Open AccessPerinatal factors affecting the gut microbiota — are they preventable?
Intestinal microbiota affects many aspects of physiological processes. The type of microbiota in the early stages of life is a critical element conditioning the development of the immune response and food tolerance. Disturbed colonization of the digestive tract resulting from the amount or diversity of bacteria colonies stimulates an inflammatory response that is associated in later life with inflammatory and autoimmune diseases. One of the elements disturbing normal colonization in the perinatal period is the operative way of delivery by caesarean section and the administration of antibiotics, used as a prophylactic measure as well as for therapeutic reasons. Based on the current state of knowledge, there is a lot of evidence demonstrating the long-term adverse effects of these modifying agents for gut microbiota, which should be kept to a minimum as far as possible. Intestinal microbiota affects many aspects of physiological processes. The type of microbiota in the early stages of life is a critical element conditioning the development of the immune response and food tolerance. Disturbed colonization of the digestive tract resulting from the amount or diversity of bacteria colonies stimulates an inflammatory response that is associated in later life with inflammatory and autoimmune diseases. One of the elements disturbing normal colonization in the perinatal period is the operative way of delivery by caesarean section and the administration of antibiotics, used as a prophylactic measure as well as for therapeutic reasons. Based on the current state of knowledge, there is a lot of evidence demonstrating the long-term adverse effects of these modifying agents for gut microbiota, which should be kept to a minimum as far as possible.
- Open Access
- 29 June 2018
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 89 (6) , 341-350
Standards of Polish Society of Gynecologists and Obstetricians in management of women with diabetes
- 29 June 2018
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 89 (6) , 341-350
Open AccessStandards of Polish Society of Gynecologists and Obstetricians in management of women with diabetes
- Open Access
- 31 May 2017
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 88 (5) , 249-254
IL16 and IL18 gene polymorphisms in women with gestational diabetes
Objectives: Gestational diabetes mellitus is a carbohydrate intolerance that occurs during pregnancy. Various inflammatory mediators are considered to be risk factors leading to GDM development. Among them are pro-inflammatory cytokines, such as IL16 and IL18. The aim of this study was to examine the association between IL16 and IL18 polymorphisms and GDM. Material and methods: This study included 204 pregnant women with GDM and 207 pregnant women with normal glucose tolerance (NGT). All samples were genotyped in duplicate using allelic discrimination assays with TaqMan® probes. Results: We observed that there was a decreased frequency of IL16 rs4778889 CC genotype carriers among women with GDM (CC vs. CT + TT: OR = 0.14; 95% CI = 0.02–1.15; p = 0.034). However, there was no significant difference in the distribution of alleles (C vs. T: OR = 0.81; 95% CI = 0.54–1.21; p = 0.30). There was a decreased frequency of the IL18 rs187238 G allele among GDM women (G vs. C: OR = 0.71; 95% CI = 0.53–0.96; p = 0.027). We also observed a decreased frequency of the IL18 rs1946518 T allele among women with GDM; however, this difference had only borderline statistical significance. We observed an association between IL18 rs187238, rs1946518 and BMI in pregnant women. Conclusions: The results of this study suggest that IL18 rs187238 and rs1946518 polymorphisms may be associated with an increased risk of GDM as well as with BMI in pregnant women. Objectives: Gestational diabetes mellitus is a carbohydrate intolerance that occurs during pregnancy. Various inflammatory mediators are considered to be risk factors leading to GDM development. Among them are pro-inflammatory cytokines, such as IL16 and IL18. The aim of this study was to examine the association between IL16 and IL18 polymorphisms and GDM. Material and methods: This study included 204 pregnant women with GDM and 207 pregnant women with normal glucose tolerance (NGT). All samples were genotyped in duplicate using allelic discrimination assays with TaqMan® probes. Results: We observed that there was a decreased frequency of IL16 rs4778889 CC genotype carriers among women with GDM (CC vs. CT + TT: OR = 0.14; 95% CI = 0.02–1.15; p = 0.034). However, there was no significant difference in the distribution of alleles (C vs. T: OR = 0.81; 95% CI = 0.54–1.21; p = 0.30). There was a decreased frequency of the IL18 rs187238 G allele among GDM women (G vs. C: OR = 0.71; 95% CI = 0.53–0.96; p = 0.027). We also observed a decreased frequency of the IL18 rs1946518 T allele among women with GDM; however, this difference had only borderline statistical significance. We observed an association between IL18 rs187238, rs1946518 and BMI in pregnant women. Conclusions: The results of this study suggest that IL18 rs187238 and rs1946518 polymorphisms may be associated with an increased risk of GDM as well as with BMI in pregnant women.
- 31 May 2017
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 88 (5) , 249-254
Open AccessIL16 and IL18 gene polymorphisms in women with gestational diabetes
Objectives: Gestational diabetes mellitus is a carbohydrate intolerance that occurs during pregnancy. Various inflammatory mediators are considered to be risk factors leading to GDM development. Among them are pro-inflammatory cytokines, such as IL16 and IL18. The aim of this study was to examine the association between IL16 and IL18 polymorphisms and GDM. Material and methods: This study included 204 pregnant women with GDM and 207 pregnant women with normal glucose tolerance (NGT). All samples were genotyped in duplicate using allelic discrimination assays with TaqMan® probes. Results: We observed that there was a decreased frequency of IL16 rs4778889 CC genotype carriers among women with GDM (CC vs. CT + TT: OR = 0.14; 95% CI = 0.02–1.15; p = 0.034). However, there was no significant difference in the distribution of alleles (C vs. T: OR = 0.81; 95% CI = 0.54–1.21; p = 0.30). There was a decreased frequency of the IL18 rs187238 G allele among GDM women (G vs. C: OR = 0.71; 95% CI = 0.53–0.96; p = 0.027). We also observed a decreased frequency of the IL18 rs1946518 T allele among women with GDM; however, this difference had only borderline statistical significance. We observed an association between IL18 rs187238, rs1946518 and BMI in pregnant women. Conclusions: The results of this study suggest that IL18 rs187238 and rs1946518 polymorphisms may be associated with an increased risk of GDM as well as with BMI in pregnant women. Objectives: Gestational diabetes mellitus is a carbohydrate intolerance that occurs during pregnancy. Various inflammatory mediators are considered to be risk factors leading to GDM development. Among them are pro-inflammatory cytokines, such as IL16 and IL18. The aim of this study was to examine the association between IL16 and IL18 polymorphisms and GDM. Material and methods: This study included 204 pregnant women with GDM and 207 pregnant women with normal glucose tolerance (NGT). All samples were genotyped in duplicate using allelic discrimination assays with TaqMan® probes. Results: We observed that there was a decreased frequency of IL16 rs4778889 CC genotype carriers among women with GDM (CC vs. CT + TT: OR = 0.14; 95% CI = 0.02–1.15; p = 0.034). However, there was no significant difference in the distribution of alleles (C vs. T: OR = 0.81; 95% CI = 0.54–1.21; p = 0.30). There was a decreased frequency of the IL18 rs187238 G allele among GDM women (G vs. C: OR = 0.71; 95% CI = 0.53–0.96; p = 0.027). We also observed a decreased frequency of the IL18 rs1946518 T allele among women with GDM; however, this difference had only borderline statistical significance. We observed an association between IL18 rs187238, rs1946518 and BMI in pregnant women. Conclusions: The results of this study suggest that IL18 rs187238 and rs1946518 polymorphisms may be associated with an increased risk of GDM as well as with BMI in pregnant women.
- Open Access
- 30 September 2016
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 87 (9) , 621-628
Costs of the use of carbetocin in the prevention of uterine atony following delivery of the infant by Caesarean section — retrospective multicenter study
The aim of this study was to compare the costs of using carbetocin in the prevention of uterine atony following delivery of the infant by Cesarean section (C-section) under epidural or spinal anesthesia with standard methods of prevention (SMP).This retrospective multicenter study was based on data from three medical centers. A questionnaire was developed to gather patient records on consumption and costs of resources related to C-section, prevention of uterine atony and postpartum hemorrhage (PPH) treatment. Six subpopulations were considered, depending on patient characteristics. The analysis covered two perspectives: that of the hospital and of the public payer.The subpopulations were homogenous, which was a premise for pooling the data. The use of carbetocin in the prevention of uterine atony following Cesarean section generates savings for hospital in comparison with SMP (oxytocin) in 5 of 6 subpopulations. The biggest savings were observed amongst patients who experienced severe PPH and reached 2.6-6.2 thousand PLN per patient. Costs of services related to C-section borne by the hospitals were higher than the refund received from a public payer. The greatest underestimation reached 12.1 thousand PLN per patient. Nevertheless, loss generated by this underfunding was lower in carbetocin versus oxytocin group.The use of carbetocin instead of SMP gives hospitals an opportunity to make savings as well as to reduce losses resulting from the underfunding of the services provided by the National Health Fund.
- 30 September 2016
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 87 (9) , 621-628
Open AccessCosts of the use of carbetocin in the prevention of uterine atony following delivery of the infant by Caesarean section — retrospective multicenter study
The aim of this study was to compare the costs of using carbetocin in the prevention of uterine atony following delivery of the infant by Cesarean section (C-section) under epidural or spinal anesthesia with standard methods of prevention (SMP).This retrospective multicenter study was based on data from three medical centers. A questionnaire was developed to gather patient records on consumption and costs of resources related to C-section, prevention of uterine atony and postpartum hemorrhage (PPH) treatment. Six subpopulations were considered, depending on patient characteristics. The analysis covered two perspectives: that of the hospital and of the public payer.The subpopulations were homogenous, which was a premise for pooling the data. The use of carbetocin in the prevention of uterine atony following Cesarean section generates savings for hospital in comparison with SMP (oxytocin) in 5 of 6 subpopulations. The biggest savings were observed amongst patients who experienced severe PPH and reached 2.6-6.2 thousand PLN per patient. Costs of services related to C-section borne by the hospitals were higher than the refund received from a public payer. The greatest underestimation reached 12.1 thousand PLN per patient. Nevertheless, loss generated by this underfunding was lower in carbetocin versus oxytocin group.The use of carbetocin instead of SMP gives hospitals an opportunity to make savings as well as to reduce losses resulting from the underfunding of the services provided by the National Health Fund.
- Open Access
- 11 March 2016
- Published by Termedia Sp. z.o.o. in Anaesthesiology Intensive Therapy
- Vol. 48 (1) , 59-60
In reply to the commentary to Commentary to "Remifentanil for labour pain relief"
- 11 March 2016
- Published by Termedia Sp. z.o.o. in Anaesthesiology Intensive Therapy
- Vol. 48 (1) , 59-60
Open AccessIn reply to the commentary to Commentary to "Remifentanil for labour pain relief"
- Open Access
- 1 November 2015
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 42 (6) , 361-364
14 Years of Polish Experience in Non-Invasive Prenatal Blood Group Diagnosis
Background: Blood cell antigens may cause maternal alloimmunization leading to fetal/newborn disorders. Non-invasive prenatal diagnostics (NIPD) of the blood group permits the determination of feto-maternal incompatibility. Aim: To evaluate 14 years of blood group NIPD at the Institute of Hematology and Transfusion Medicine (IHTM) in Warsaw. Methods: Plasma DNA from 536 RhD-negative, 24 Rhc-negative, 26 RhE-negative, 43 K-negative, and 42 HPA-1a-negative pregnant women was examined by real-time PCR to detect RHD, RHCE*c, RHCE*E, RHCE*C,KEL*01 and HPA*1A, respectively. We tested for CCR5, SRY or bi-allelic polymorphisms and quantified the total or fetal DNA. Results: The results of fetal antigen status prediction by NIPD in all but one case (false-positive result of KEL*01) were correct taking neonate serology as a reference. It was confirmed that all negative results of NIPD contained fetal DNA except for four cases where there was no difference between the parents' polymorphisms. Conclusions: A fetal genotype compatible with the mother was determined in 25% of all pregnancies tested at the IHTM for the fetal blood group. These cases were not at risk of disease, so it was possible to avoid invasive procedures.
- 1 November 2015
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 42 (6) , 361-364
Open Access14 Years of Polish Experience in Non-Invasive Prenatal Blood Group Diagnosis
Background: Blood cell antigens may cause maternal alloimmunization leading to fetal/newborn disorders. Non-invasive prenatal diagnostics (NIPD) of the blood group permits the determination of feto-maternal incompatibility. Aim: To evaluate 14 years of blood group NIPD at the Institute of Hematology and Transfusion Medicine (IHTM) in Warsaw. Methods: Plasma DNA from 536 RhD-negative, 24 Rhc-negative, 26 RhE-negative, 43 K-negative, and 42 HPA-1a-negative pregnant women was examined by real-time PCR to detect RHD, RHCE*c, RHCE*E, RHCE*C,KEL*01 and HPA*1A, respectively. We tested for CCR5, SRY or bi-allelic polymorphisms and quantified the total or fetal DNA. Results: The results of fetal antigen status prediction by NIPD in all but one case (false-positive result of KEL*01) were correct taking neonate serology as a reference. It was confirmed that all negative results of NIPD contained fetal DNA except for four cases where there was no difference between the parents' polymorphisms. Conclusions: A fetal genotype compatible with the mother was determined in 25% of all pregnancies tested at the IHTM for the fetal blood group. These cases were not at risk of disease, so it was possible to avoid invasive procedures.
- Open Access
- 30 June 2015
- Published by The Nencki Institute of Experimental Biology, Polish Academy of Sciences in Acta Neurobiologiae Experimentalis
- Vol. 75 (2) , 172-191
The influence of BDNF on human umbilical cord blood stem/progenitor cells: Implications for stem cell-based therapy of neurodegenerative disorders
Umbilical cord blood (UCB)-derived stem/progenitor cells (SPCs) have demonstrated the potential to improve neurologic function in different experimental models. SPCs can survive after transplantation in the neural microenvironment and indu ce neuroprotection, endogenous neurogenesis by secreting a broad repertoire of trophic and immunomodulatory cytokines. In this study, the influence of brain-derived neurotrophic factor (BDNF) pre-treatment was comprehensively evaluated in a UCB-derived lineage-negative (Lin−) SPC population. UCB-derived Lin− cells were evaluated with respect to the expression of (i) neuronal markers using immunofluorescence staining and (ii) specific (TrkB) receptors for BDNF using flow cytometry. Next, after BDNF pre-treatment, Lin− cells were extensively assessed with respect to apoptosis using Western blotting and proliferation via BrdU incorporation. Furthermore, NT-3 expression levels in Lin− cells using RQ PCR and antioxidative enzyme activities were assessed. We demonstrated neuronal markers as well as TrkB expression in Lin− cells and the activation of the TrkB receptor by BDNF. BDNF pre-treatment diminished apoptosis in Lin− cells and influenced the proliferation of these cells. We observed significant changes in antioxidants as well as in the increased expression of NT-3 in Lin− cells following BDNF exposure. Complex global miRNA and mRNA profiling analyses using microarray technology and GSEA revealed the differential regulation of genes involved in the proliferation, gene expression, biosynthetic processes, translation, and protein targeting. Our results support the hypothesis that pre-treatment of stem/progenitor cells could be beneficial and may be used as an auxiliary strategy for improving the properties of SPCs.
- 30 June 2015
- Published by The Nencki Institute of Experimental Biology, Polish Academy of Sciences in Acta Neurobiologiae Experimentalis
- Vol. 75 (2) , 172-191
Open AccessThe influence of BDNF on human umbilical cord blood stem/progenitor cells: Implications for stem cell-based therapy of neurodegenerative disorders
Umbilical cord blood (UCB)-derived stem/progenitor cells (SPCs) have demonstrated the potential to improve neurologic function in different experimental models. SPCs can survive after transplantation in the neural microenvironment and indu ce neuroprotection, endogenous neurogenesis by secreting a broad repertoire of trophic and immunomodulatory cytokines. In this study, the influence of brain-derived neurotrophic factor (BDNF) pre-treatment was comprehensively evaluated in a UCB-derived lineage-negative (Lin−) SPC population. UCB-derived Lin− cells were evaluated with respect to the expression of (i) neuronal markers using immunofluorescence staining and (ii) specific (TrkB) receptors for BDNF using flow cytometry. Next, after BDNF pre-treatment, Lin− cells were extensively assessed with respect to apoptosis using Western blotting and proliferation via BrdU incorporation. Furthermore, NT-3 expression levels in Lin− cells using RQ PCR and antioxidative enzyme activities were assessed. We demonstrated neuronal markers as well as TrkB expression in Lin− cells and the activation of the TrkB receptor by BDNF. BDNF pre-treatment diminished apoptosis in Lin− cells and influenced the proliferation of these cells. We observed significant changes in antioxidants as well as in the increased expression of NT-3 in Lin− cells following BDNF exposure. Complex global miRNA and mRNA profiling analyses using microarray technology and GSEA revealed the differential regulation of genes involved in the proliferation, gene expression, biosynthetic processes, translation, and protein targeting. Our results support the hypothesis that pre-treatment of stem/progenitor cells could be beneficial and may be used as an auxiliary strategy for improving the properties of SPCs.
- Open Access
- 7 March 2015
- Published by Termedia Sp. z.o.o. in Anaesthesiology Intensive Therapy
- Vol. 47 (1) , 82-86
Remifentanyl w łagodzeniu bólu porodowego
Labour is thought to be one of the most intense and painful experiences in a woman's life. Numerous studies using a Visual Analogue Scale invariably demonstrate that 20% of women in labour describe the pain as "unbearable" and 60% describe the pain as "very intense". Since the mid-1980s, continuous epidural analgesia during labour has been considered the gold standard of labour anaesthesia and is currently the most frequently used. There are situations in which this type of analgesia could not be used. An alternative pain management is administration of parenteral opioids, the most frequently used of which is pethidine. Its use is associated with adverse effects and unsatisfactory analgesia. Since the second half of the 20th century, a new generation of opioids, such as fentanyl or remifentanil, has been used. Despite their much better pharmacokinetic and pharmacodynamic parameters, obstetricians, midwives and neonatologists are most aware of pethidine, probably because it has been used for the longest period of time, despite its disadvantages and the risk that its use entails. The drug that is nearest to ideal is remifentanil. The countries in which it is widely used as an alternative type of labour anaesthesia have developed practice standards or guidelines practice. Guidelines and alternatives to pethidine protocols for effective labour analgesia in Poland might be merited.
- 7 March 2015
- Published by Termedia Sp. z.o.o. in Anaesthesiology Intensive Therapy
- Vol. 47 (1) , 82-86
Open AccessRemifentanyl w łagodzeniu bólu porodowego
Labour is thought to be one of the most intense and painful experiences in a woman's life. Numerous studies using a Visual Analogue Scale invariably demonstrate that 20% of women in labour describe the pain as "unbearable" and 60% describe the pain as "very intense". Since the mid-1980s, continuous epidural analgesia during labour has been considered the gold standard of labour anaesthesia and is currently the most frequently used. There are situations in which this type of analgesia could not be used. An alternative pain management is administration of parenteral opioids, the most frequently used of which is pethidine. Its use is associated with adverse effects and unsatisfactory analgesia. Since the second half of the 20th century, a new generation of opioids, such as fentanyl or remifentanil, has been used. Despite their much better pharmacokinetic and pharmacodynamic parameters, obstetricians, midwives and neonatologists are most aware of pethidine, probably because it has been used for the longest period of time, despite its disadvantages and the risk that its use entails. The drug that is nearest to ideal is remifentanil. The countries in which it is widely used as an alternative type of labour anaesthesia have developed practice standards or guidelines practice. Guidelines and alternatives to pethidine protocols for effective labour analgesia in Poland might be merited.